Harvest One Cannabis Inc., of Vancouver, British Columbia, through its wholly owned subsidiary, Satipharm AG, said its capsules were used in a phase II trial by Phytotech Therapeutics Ltd., a wholly owned subsidiary of MMJ Phytotech Ltd., of Nedlands, Australia.